Purpose Accurate recording of immunization status is essential for the evaluation of any immunization programme. In September 2006, 7-valent pneumococcal conjugate vaccination (PCV7) was introduced into the UK's routine childhood immunization programme. This study validated the PCV7 immunization status of children aged 2 years recorded in the IMS Disease Analyses (DA) database. Methods The PCV7 vaccination uptake rate for children born in 2008 in the IMS DA database was calculated. A sample of 173 of the 2497 children not recorded as vaccinated was identified, and a questionnaire was sent to each of their general practitioners to ascertain the child's true PCV7 vaccination status. Results In the IMS DA data of 15 237 children born in 2008, 12 740 (83.6%) had a vaccination record of PCV7. One-hundred and eleven of the 167 questionnaires sent to the child's general practitioners were returned, giving an adjusted response rate of 111/167 (66.5%). Based on the general practitioners' responses, 71 (64%) of these children were fully vaccinated according to their general practitioner's records making the revised estimated vaccination rate for this cohort 94.1% Conclusion This validation study has shown that caution is needed if using historical IMS patient-level data to analyse the effectiveness of PCV7 as there is a potential under-recording of immunization leading to under representation of vaccination rates by approximately 10%.
INTRODUCTION
Childhood immunization against infectious diseases is a key component of preventive healthcare. In September 2006, 7-valent pneumococcal conjugate vaccination (PCV7) was introduced into the UK routine childhood immunization programme at 2 and 4 months of age, with a booster dose after 12 months of age. 1 To evaluate its impact and effectiveness on child's health, it is important to have an accurate measure of uptake that can be used to investigate the association between the incidence of pneumococcal infection diseases and PCV7 (Prevnar 7®) usage. One possible source of data on immunization uptake is the IMS Disease Analyser (DA). It is a private, international health care company that gathers anonymized data from a nationally representative sample of UK general practices. 2 The data gathered from the sampled practices are used to calculate projected national vaccination coverage. In this study, the accuracy of IMS-DA summary statistics of vaccination uptake was ascertained by comparing patient-level data from the database with the immunization status reported by the general practitioner (GP) after reviewing the individual's health record.
METHODS

Study design
This cross sectional observational study was designed to investigate the actual immunization status of children with no record of having received PCV7 in the IMS DA database.
Data source
The IMS DA (formally known as Mediplus) derives anonymized data from the electronic health records of approximately 3 million patients registered with over 500 GPs working in 125 general practices throughout the UK. Automatically downloaded data includes demographic characteristics, diagnoses and prescriptions. Drugs are coded based on the Anatomical Therapeutic Chemical classification and the Read Codes used in UK general practice for symptoms, and diagnoses are mapped to ICD-10 (International Statistical Classification Disease, 10th Revision) by the IMS health team. 3 
Source population
The target population were children born in 2008. A list was compiled of children who by the age of two had no record of a PCV7 record in the IMS DA database. This list was compiled by identifying those who had no event or prescription codes corresponding to pneumococcal vaccination (Read Codes listed in Table 1 or ATC code J07A7). A computer generated random sample of 173 apparently unvaccinated children was made, and in December 2010, a letter and one page questionnaire, with the child's age, gender, date of birth and patient ID, were sent by IMS DA to the relevant GP asking them to review the child's health record and report if they had received Prevnar 7® vaccine and which of the three doses they had been given. The GP received £15 for the completion of the questionnaire.
Sample size estimation for questionnaire study
The sample size was based on some preliminary work with IMS DA data indicating that of the approximately 18 000 children aged 0-2 years registered approximately 3600 (15%) did not have any coded record of PCV7 immunization. Assuming that 5% of these children were immunized but unrecorded, the sample size needed to detect this with 95% confidence would be 132 patients (OpenEpi, Version 3, open source calculator-SSPropor). We recognized that it was unlikely to get data on every child so the sample was increased to 173, allowing for a 25% none response rate.
ETHICAL APPROVAL
This protocol for this study was approved by the IMS Independent Scientific and Ethical Advisory Committee on 10 October 2008.
RESULTS
The IMS DA database identified 15 237 children born in 2008; of these, 12 740 (83.6%) had a coded record of PCV7 vaccination (Figure 1) . A random sample of 173 was taken from the 2497 children with no vaccination record. Six children could not be followed up as their practice had stopped contributing data to IMS DA (n = 5), and another practice encountered a technical problem (n = 1). Out of 167 questionnaires sent to the children's GP, 111 questionnaires were returned, giving an adjusted response rate of 111/167 (66.5%). Based on the GPs' responses, 71/111 (64.0%) were fully vaccinated (three doses of PCV7 given), 3/111 (2.7%) partially vaccinated (only one or two doses given), 28/111 (25.2%) were unvaccinated and for 9/111 (8.1%), their vaccination status was unknown ( Figure 1 ). Extrapolating these observations from our subsample of 111 children to the IMS DA cohort would mean that an extra 1597 children had been fully vaccinated with PCV7, 68 partially vaccinated, 630 unvaccinated and for 202 children, their vaccination status was unknown. Thus, the percentage of fully vaccinated children within this cohort becomes 94.1% (14 337/ 15 237), rather than 83.6%.
The worst case scenario would be if all of the children for whom we had no response from their GPs were unprotected. Combining these with the children who were only partially vaccinated or for whom vaccination status was unknown yields a minimum vaccination rate of 90.6%. Conversely, if one included the partially immunized, the vaccination rate rises to 94.5% (14 405/15 237), and with the inclusion of the unknowns, the vaccination rate would rise further to 95.9% (14 608/15 237). Why might there be this degree of under reporting of vaccination uptake in database analysis? One can only speculate, but possible explanations include no access to the patients' electronic health record at the time of immunization, and lack of triggers to enter vaccine administration on the electronic health record (for example, the vaccine is available in practice without the need for personalized prescription). The data may also sometimes be entered into the electronic health record as a free text entry rather than Read coded, and this means it is not recognized in routine searches and retrieval. The fee general practices are paid for each immunization administered might theoretically incentivize the recording child immunization, but the payment is small; its existence may not be apparent to staff uninvolved with the financial and business aspects of the practice, and it rarely impacts on the income of salaried staff 5, 6 . Problems with the computer system has been highlighted as a barrier to fully implement pneumococcal immunization programmes in a previous study 5 . Additionally, immunization has never been included as an indicator of quality in the Quality and Outcomes Framework (QOF) scheme, which has achieved better documentation and some improved clinical care in other areas of health. 7 What are the clinical implications of our research? Although this work focused only on PCV7 immunization, it is likely to be relevant to all the other childhood immunization programmes, including influenza, measles, mumps and rubella (MMR), rotavirus vaccine and meningitis B and C vaccines. A multifaceted approach is needed to improve the completeness and standardization of the recording of vaccination in the primary care electronic health record. This will include ensuring relevant members of the primary care team, including health visitors and school nurses can, and do, access the child's EHR for timely entry of data. Vigilance is also required to ensure that when vaccines are administered in a setting other than primary care, for example in a hospital setting or private health care facility, that the child's GP is informed so that the information can be entered into the child's EHR. With such changes, the completeness of databases derived from the primary care EHR will be improved, and IMS DA will be able to offer more valid data that can be used in the evaluation of vaccination coverage and also to investigate the impact of vaccines on specific disease prevention.
STRENGTH AND LIMITATIONS
The major strength of our study is that the IMS DA uses data broadly representative of the UK population in terms of age and gender although there is under representation of smaller practices and of practices in Scotland and Northern Ireland 2 . This is the first study to validate immunization statistic estimates from the IMS DA. The limitation of the study is that it focused only on underreporting; no attempt was made to confirm the validity of positive coding of vaccination. A third of GPs did not respond to the enquiry, and there is a risk that there may be responder bias with the practitioners of unvaccinated children being less likely to respond. This was recognized in our calculation of the worst case scenario.
CONCLUSIONS
This validation study has demonstrated that individual patient-level data analyses based on IMS data cannot reliably be employed to investigate the association between PCV7 vaccination and the incidence of pneumococcal infection diseases.
The under reporting of vaccination in IMS data arises because of failure to routinely code all childhood immunizations in the primary care electronic health record, and we need to better understand the challenges encountered in practice.
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KEY POINTS
• Accurate recording of immunization status is essential for any immunization programme evaluation.
